Our portfolio

This is our portfolio with which we are 100% transparent.

Since 2015 we have built up a diversified portfolio with growing value. We put a lot of work and specialized knowledge into selecting the best investment opportunities - that's why we only make public approximately 3% of those we analyse.

in co-investment

direct investment

investee companies

in business

All the investment opportunities we publish in Capital Cell have a reference investor who has conducted its own analysis, its own due diligence and validated the price per share. This reinforces our confidence that the project and its team are capable of generating a return.


 
 
 
851.000€
Round size
  • December   2024
  • Biotechnology
  • In business
602.000€
Round size
  • December   2024
  • Biotechnology
  • In business
1.884.000€
Round size
  • December   2024
  • Biotechnology
  • In business
1.323.000€
Round size
  • October   2024
  • Medical devices
  • In business
1.001.000€
Round size
  • October   2024
  • Medical devices
  • In business
556.000€
Round size
  • October   2024
  • Diagnostics
  • In business
560.000€
Round size
  • September   2024
  • Medical devices
  • In business
636.000€
Round size
  • August   2024
  • Medical devices
  • In business
505.000€
Round size
  • July   2024
  • Digital health
  • In business
799.000€
Round size
  • July   2024
  • Diagnostics
  • In business
797.000€
Round size
  • June   2024
  • Digital health
  • In business
424.000€
Round size
  • June   2024
  • Medical devices
  • In business
1.063.000€
Round size
  • May   2024
  • Biotechnology
  • In business
1.126.000€
Round size
  • April   2024
  • Digital health
  • In business
1.179.000€
Round size
  • March   2024
  • Medical devices
  • In business
1.243.000€
Round size
  • February   2024
  • New drugs
  • In business
586.000€
Round size
  • February   2024
  • Digital health
  • In business
722.000€
Round size
  • February   2024
  • Medical devices
  • In business
1.184.000€
Round size
  • January   2024
  • Biotechnology
  • In business
631.000€
Round size
  • January   2024
  • Medical devices
  • In business
893.000€
Round size
  • January   2024
  • Medical devices
  • In business